Literature DB >> 7531991

Colony-stimulating factor-producing tumours: production of granulocyte colony-stimulating factor and interleukin-6 is secondary to interleukin-1 production.

R Tsuyuoka1, T Takahashi, Y Sasaki, Y Taniguchi, M Fukumoto, A Suzuki, K Nakamura, S Kobayashi, T Kudo, K Nakao.   

Abstract

We have reported that tumours producing colony-stimulating factor (CSF) also secrete interleukin-1 (IL-1) and IL-6. In the present study, we characterised the role played by IL-1 in CSF production. IL-1 receptor antagonist inhibited the production of granulocyte (G)-CSF and IL-6 by approximately 90% in CSF-producing human lung carcinoma cell lines. Similar results were obtained with hydrocortisone, which suppresses IL-1 gene expression. In contrast, 15 non-CSF-producing human lung carcinoma cell lines did not show detectable IL-1 production, although seven of them were induced to produce G-CSF and IL-6 by exogenous IL-1 alpha. Cell lines that responded to IL-1 alpha, including the CSF-producing lines, expressed receptors for IL-1 alpha. These results indicate that CSF-producing tumours can be characterised by their constitutive IL-1 production, IL-1 receptor expression and IL-1-dependent excess production of G-CSF and IL-6. Furthermore, transcription factor(s) may be involved in the abnormal IL-1 alpha production.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7531991     DOI: 10.1016/0959-8049(94)00347-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

1.  Diffuse fluorodeoxyglucose-positron uptake in the bone marrow of a patient with granulocyte colony-stimulating factor-producing pleomorphic carcinoma of the lung: A case report.

Authors:  Takashi Makino; Yoshinobu Hata; Hajime Otsuka; Satoshi Koezuka; Nao Kikuchi; Kazutoshi Isobe; Naobumi Tochigi; Kazutoshi Shibuya; Sakae Homma; Akira Iyoda
Journal:  Mol Clin Oncol       Date:  2017-05-29

2.  A pleomorphic carcinoma of the lung producing multiple cytokines and forming a rapidly progressive mass-like opacity.

Authors:  Masataka Matsumoto; Takashi Nakayama; Daiki Inoue; Kazufumi Takamatsu; Ryo Itotani; Manabu Ishitoko; Shinko Suzuki; Minoru Sakuramoto; Yoshiaki Yuba; Osamu Yoshie; Masaya Takemura; Motonari Fukui
Journal:  BMC Cancer       Date:  2014-08-13       Impact factor: 4.430

3.  Systemic chemotherapy with pronounced efficacy and neutropenia in a granulocyte-colony stimulating factor-producing advanced gastric neuroendocrine carcinoma.

Authors:  Nobuhiro Tsuruta; Kotoe Takayoshi; Shuji Arita; Tomomi Aikawa; Hiroshi Ariyama; Hitoshi Kusaba; Kenoki Ohuchida; Eishi Nagai; Kenichi Kohashi; Minako Hirahashi; Kyoko Inadomi; Mamoru Tanaka; Kosuke Sagara; Yuta Okumura; Kenta Nio; Michitaka Nakano; Masafumi Nakamura; Yoshinao Oda; Koichi Akashi; Eishi Baba
Journal:  Oncol Lett       Date:  2017-06-02       Impact factor: 2.967

4.  Regulation of granulocyte colony-stimulating factor and parathyroid hormone-related protein production in lung carcinoma cell line OKa-C-1.

Authors:  Y Uemura; H Nakata; M Kobayashi; R Harada; Y Asahi; H Taguchi
Journal:  Jpn J Cancer Res       Date:  2000-09

5.  A case of squamous cell carcinoma of the lung that produced granulocyte colony-stimulating factor and interleukin-6.

Authors:  Nobuhiro Takeuchi; Kento Yamamoto; Kazuyoshi Naba
Journal:  Case Rep Med       Date:  2013-04-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.